Inhibitors of dopamine inactivating systems as antiparkinson drugs
Youdim, M.B.
Advances in Neurology 53: 483-488
1990
ISSN/ISBN: 0091-3952 PMID: 2239488 Document Number: 359441
Document emailed within 1 workday
Related Documents
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Retterstol, N. 1973: Antiparkinson drugs--abuse among youth Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(31): 2332
Stock, B.; Spiteller, G. 1979: Metabolism of antiparkinson drugs. An example of competitive hydroxylation Arzneimittel-Forschung 29(4): 610-615
Parker, E.M.; Cubeddu, L.X. 1986: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores Journal of Pharmacology and Experimental Therapeutics 237(1): 179-192
David, J.; Kaul, C.L.; Grewal, R.S. 1979: Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice Indian Journal of Experimental Biology 17(8): 760-764
Ben Hadj Ali, B.; Dogui, M.; Ben Ammou, S.; Lôo, H. 1995: Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal L'Encephale 21(3): 209-215
Wustmann, C.; Rudolph, E.; Schwipper, U.; Ranacher, B.; Fischer, H.D.; Schmidt, J. 1982: Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum Acta Biologica et Medica Germanica 41(6): 575-579
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79
Giros, B.; Gros, C.; Solhonne, B.; Schwartz, J.C. 1986: Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies Molecular Pharmacology 29(3): 281-287
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Martínez-Suárez, M.M.; Blázquez-Menes, B. 2000: Estimation of the prevalence of Parkinson's disease in Asturia, Spain. a pharmacoepidemiological study of the consumption of antiparkinson drugs Revista de Neurologia 31(11): 1001-1006
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Rao, N.M.; Pattabiraman, T.N. 1985: Natural plant enzyme inhibitors: comparison of the action of tuber protease inhibitors on animal pancreatic systems Indian Journal of Biochemistry and Biophysics 22(6): 373-375
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Bonnici, F.; Omar, M.A. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors have a more beneficial effect on biochemical parameters than low-dose thiazides South African Medical Journal 80(5): Suppl 6
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Dagnino, L.; Paterson, A.R. 1990: Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides Cancer Research 50(20): 6549-6553
Piesche, L.; Hilse, H.; Oehme, P. 1979: Inhibitors of dopamine-beta-hydroxylase as potential antihypertensives (proceedings) Die Pharmazie 34(5-6): 332-334
Mogilnicka, E.; Przewlocka, B. 1975: The influence of dopamine-beta-hydroxylase inhibitors on avoidance reaction in rat Polish Journal of Pharmacology and Pharmacy 27(5): 513-519